bNAbs – Global Health Press

Latest Science

First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells...

4 October, 2022

6 min read

Latest Science

HIV vaccine that generates broadly neutralizing antibodies passes first safety and proof-of-concept study in humans

Scientists are engineering vaccines that turn cells into antibody factories The Conference on Retroviruses and Opportunistic Infections (CROI 2020) heard this week how scientists had, for the first time, devised a...

16 March, 2020

10 min read

Latest Science

Experimental HIV vaccine successfully elicits broadly neutralizing antibodies to the virus

An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety...

21 November, 2019

6 min read

Latest Science

New insight on potent HIV antibody could improve vaccine design

Early mutation in neutralizing antibody gives it flexibility to adapt to virus’s changes In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region...

21 February, 2019

2 min read

Latest Science

TSRI, IAVI researchers harness antibody evolution on path to AIDS vaccine

A series of new studies led by scientists at The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) describe a potential vaccination strategy to jump-start the selection and evolution...

16 September, 2016

6 min read

Latest Science

Vaccine Institute tackles new roadblock in developing HIV vaccine

A discovery made by Duke researchers is shedding light on a potential new strategy for producing an effective HIV vaccine. The human body is capable under certain conditions of creating broadly neutralizing HIV-1...

26 August, 2016

3 min read

Tag - bNAbs

First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

HIV vaccine that generates broadly neutralizing antibodies passes first safety and proof-of-concept study in humans

Experimental HIV vaccine successfully elicits broadly neutralizing antibodies to the virus

New insight on potent HIV antibody could improve vaccine design

TSRI, IAVI researchers harness antibody evolution on path to AIDS vaccine

Vaccine Institute tackles new roadblock in developing HIV vaccine